How to Start GLP-1s With Confidence

Starting a GLP-1 means easing into it over weeks: a low starting dose a provider steps up gradually as your body adjusts. That slow climb is the whole design — it gives your system time to settle, which keeps the early side effects mild.

7 min read
SemaglutideGLP-1 AgonistsMetabolic HealthTirzepatide
On this page0% read

Start Here

A GLP-1 — glucagon-like peptide-1 receptor agonist, the class that includes semaglutide and tirzepatide — is a medication you ease into over weeks. You start on a low dose, and a provider steps it up gradually as your body adjusts. That slow climb is the whole design: it gives your system time to settle at each step, which keeps the early side effects mild and lets the appetite changes set in steadily.

Most people decide they want to try a GLP-1 long before they actually start one. The deciding is the hard part — the starting is mostly a matter of doing it in the right order, slowly, and with the right person.

Are You a Candidate?

GLP-1 medications are prescribed for weight management in two groups: adults with obesity — a body mass index (BMI) of roughly 30 or higher — and adults who are overweight (a BMI around 27 or higher) who also have at least one weight-related condition such as high blood pressure 12. The trials behind them enrolled adults in exactly that range 45. If that describes you, you're in the population these were built for, and you can take that read of your own fit seriously — some routes, telehealth especially, are designed for people to start from that self-assessment.

Your health history is the other half. A personal or family history of medullary thyroid cancer (MTC, a specific thyroid tumor) or MEN2 (multiple endocrine neoplasia type 2, an inherited condition that raises that cancer risk) rules these drugs out entirely — they carry a boxed warning, the FDA's strongest, for exactly that reason 12. A history of pancreatitis or gallbladder disease, or pregnancy, falls into a softer category: cautions to raise with a provider who can weigh them with you 2.

It's possible to estimate whether you're a candidate from the basics, then work with a provider to confirm it and sort through anything in your history. The full safety and monitoring picture lives in the hub, GLP-1s and Longevity.

How to Get a Prescription

There are three ordinary routes to a GLP-1 prescription: telehealth, a weight-management or obesity-medicine clinic, and primary care. None is automatically better than the others — they differ mostly in convenience, cost, and how much hands-on guidance you get. What makes any of them trustworthy is the same thing whichever door you walk through: a prescription from a licensed health care provider, filled at a state-licensed pharmacy 3. Get those two right and the supply side is sorted.

Compounded versions are common too, especially through telehealth — prepared by a pharmacy rather than the branded product. From a state-licensed pharmacy with a licensed provider behind it, that's a legitimate route — a difference worth knowing, not worrying about 3.

Start Low, Go Slow: What Titration Means

Titration is the core of starting well, and it's simpler than the word makes it sound: the dose starts low — a starting dose, not the full strength — and steps up on a schedule, with a minimum stretch of time at each level, usually at least four weeks before an increase 12.

Here's why it's built that way. GLP-1s work partly by slowing your stomach, which is what can bring on the early nausea — so the dose climbs slowly on purpose, giving your gut time to adapt at each step. That gradual pace is exactly what keeps the side effects manageable as you build up to the dose that delivers the full effect.

The pace is meant to flex to you, which is why a provider runs it. The prescribing instructions allow for exactly that: if a dose isn't sitting well, a provider can keep you there longer before the next step instead of moving up on schedule 1. A provider also answers the "is this normal?" questions in week two — which is why titration is a supervised process rather than a schedule to run off a chart. The people who have the hardest time are usually the ones who rushed the climb or went without that guidance.

One thing worth internalizing early: the payoff comes from staying on the medication over the long run, not from reaching the top dose quickly. There's no advantage to rushing the climb — and if you stop, the weight tends to return, because the effect depends on continued treatment 67. The hub covers that evidence in full, GLP-1s and Longevity.

What the First Weeks Actually Feel Like

How soon does it start, and how do the first weeks feel? Mostly, the early weeks are your body getting used to the medication. The side effects show up first and then settle — that's the most consistent finding across the evidence: the common effects are gastrointestinal, they're predominantly mild-to-moderate, they peak while the dose is climbing, and they ease with time 145. That arc is Established — two independent trial reports and the FDA labels all describe the same pattern.

The common effects are nausea, looser or softer stools, occasional vomiting, and constipation, and they're best understood per drug rather than as one class number. On the 2.4 mg semaglutide dose, nausea was reported by roughly 44% of people in the trials; on tirzepatide, it ran around 25–29% across doses 12. Those are how often the effect turned up in the trial populations, not a forecast for any one person — plenty of people experience minimal symptoms.

Timeframe
First days to weeks
What's common
Gastrointestinal (GI — stomach and gut) effects appear as the dose starts and climbs — nausea, softer or looser stools, occasional vomiting, or constipation; mostly mild-to-moderate
What it usually means
Your body is adjusting to the medication — the expected part of the ramp
Timeframe
Through the dose-escalation weeks
What's common
Effects tend to peak while the dose is being stepped up
What it usually means
The most-noticeable stretch, and the reason the increases are spaced out and provider-led
Timeframe
Over time
What's common
Effects typically ease as your body settles at a dose
What it usually means
For most people this is a starting phase, not the new normal — the rough part comes early and eases

A few symptoms are worth a call rather than a wait-and-see: severe or persistent vomiting, signs of dehydration, or severe abdominal pain — the kind that maps to the pancreatitis and gallbladder cautions 2. Knowing where that line sits is what lets you relax about everything below it.

On the needle itself: the medication comes in a single-dose, pre-filled pen, given under the skin in the abdomen, thigh, or upper arm, once a week 1 — a metered weekly injection, and your provider walks you through the technique the first time. Many people also notice the appetite changes settling in around now; Food Noise and GLP-1s covers what that shift feels like.

What to Ask Your Provider

The right questions turn a nervous first appointment into a guided one. A handful does most of the work — this is the short list to bring, not the full monitoring panel (the hub covers that):

  • What starting dose, and how will we set the pace?
    How my titration — the gradual dose increase — gets decided for me specifically.
  • What do we do if a dose is hard to tolerate?
    Whether we'll hold at a dose longer rather than push the next increase.
  • What's normal, and what's worth a call?
    Which gastrointestinal (GI — stomach and gut) effects are expected, and which symptoms mean I should reach out.
  • Given my history, any reasons for caution?
    The contraindication-and-caution conversation: thyroid history, pancreatitis, gallbladder, pregnancy.
  • How will we handle the prescription and pharmacy?
    Getting the medication through a licensed provider and a state-licensed pharmacy.

The complete monitoring and follow-up picture — labs, longer-term check-ins, the full safety panel — lives in the hub: GLP-1s and Longevity.

Taking the First Step

Starting a GLP-1 well comes down to pacing it slowly and having someone manage that pace with you. The dose climbs gradually, the side effects that worry people most are usually mild and front-loaded, and the single highest-leverage move a nervous beginner can make is to start with a licensed provider who titrates carefully. That's what turns starting into a guided, adjustable process you take one week at a time.

The move that matters most is the simplest one: start low, with a provider who adjusts the pace to you.

Related reading: GLP-1s and Longevity for the complete safety, monitoring, and pharmacology picture, and Food Noise and GLP-1s for what the appetite change feels like.

References

  1. WEGOVY (semaglutide injection) — Prescribing Information, including Boxed Warning. Novo Nordisk / U.S. Food and Drug Administration. 2024. FDA label
  2. ZEPBOUND (tirzepatide injection) — Prescribing Information, including Boxed Warning. Eli Lilly / U.S. Food and Drug Administration. 2023. FDA label
  3. "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss." U.S. Food and Drug Administration, Drug Alerts and Statements. 2026. FDA
  4. Wilding JPH, Batterham RL, Calanna S, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine. 2021. PubMed
  5. Jastreboff AM, Aronne LJ, Ahmad NN, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine. 2022. PubMed
  6. Wilding JPH, Batterham RL, Davies M, et al. "Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension." Diabetes, Obesity and Metabolism. 2022. PubMed
  7. Aronne LJ, Sattar N, Horn DB, et al. "Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial." JAMA. 2024. PubMed